Exosomal Dvl3 promoted the aggressive phenotypic transformation of RA-FLS via wnt pathway

References

• Nygaard G, Firestein GS. Restoring synovial homeostasis in rheumatoid arthritis by targeting fibroblast-like synoviocytes. Nat Rev Rheumatol. 2020;16(6):316–333.
   PubMed Web of Science ®Google Scholar
• Bustamante MF, Garcia-Carbonell R, Whisenant KD, et al. Fibroblast-like synoviocyte metabolism in the pathogenesis of rheumatoid arthritis. Arthritis Res Ther. 2017;19(1):110.
   PubMedGoogle Scholar
• Ha YJ, Choi YS, Han DW, et al. PIM-1 kinase is a novel regulator of proinflammatory cytokine-mediated responses in rheumatoid arthritis fibroblast-like synoviocytes. Rheumatology (Oxford). 2019;58(1):154–164.
   PubMedGoogle Scholar
• Li G, Liu Y, Meng F, et al. LncRNA MEG3 inhibits rheumatoid arthritis through miR-141 and inactivation of AKT/mTOR signalling pathway. J Cell Mol Med. 2019;23(10):7116–7120.
   PubMed Web of Science ®Google Scholar
• Miao C-g, Yang Y-y, He X, et al. Wnt signaling pathway in rheumatoid arthritis, with special emphasis on the different roles in synovial inflammation and bone remodeling. Cell Signal. 2013;25(10):2069–2078.
   PubMed Web of Science ®Google Scholar
• Liang JJ, Li HR, Chen Y, et al. ZNRF3 regulates Collagen-Induced arthritis through NF-kB and wnt pathways. Inflammation. 2020;43(3):1077–1087.
   PubMedGoogle Scholar
• Sharma M, Castro-Piedras I, Simmons GE, et al. Dishevelled: a masterful conductor of complex wnt signals. Cell Signal. 2018;47:52–64.
   PubMed Web of Science ®Google Scholar
• Habas R, Kato Y, He X. Wnt/frizzled activation of rho regulates vertebrate gastrulation and requires a novel formin homology protein Daam1. Cell. 2001;107(7):843–854.
   PubMed Web of Science ®Google Scholar
• Tanegashima K, Zhao H, Dawid IB. WGEF activates rho in the Wnt-PCP pathway and controls convergent extension in xenopus gastrulation. Embo J. 2008;27(4):606–617.
   PubMed Web of Science ®Google Scholar
• Pant S, Hilton H, Burczynski ME. The multifaceted exosome: biogenesis, role in normal and aberrant cellular function, and frontiers for pharmacological and biomarker opportunities. Biochem Pharmacol. 2012;83(11):1484–1494.
   PubMed Web of Science ®Google Scholar
• Xiao CY, Pan YF, Guo XH, et al. Expression of β-catenin in rheumatoid arthritis fibroblast-like synoviocytes. Scand J Rheumatol. 2011;40(1):26–33.
   PubMed Web of Science ®Google Scholar
• Liu XZ, Fan J, Qi K, et al. Dishevelled2 promotes apoptosis and inhibits inflammatory cytokine secretion in rheumatoid arthritis fibroblast-like synoviocytes through crosstalk with the NF-κB pathway. Oncotarget. 2017;8(8):12649–12663.
   PubMedGoogle Scholar
• Zhang Q, Liu J, Zhang M, et al. Apoptosis induction of Fibroblast-Like synoviocytes is an important molecular-mechanism for herbal medicine along with its active components in treating rheumatoid arthritis. Biomolecules. 2019;9(12):795.
   PubMed Web of Science ®Google Scholar
• Bartok B, Firestein GS. Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis. Immunol Rev. 2010;233(1):233–255.
   PubMed Web of Science ®Google Scholar
• Falconer J, Murphy AN, Young SP, et al. Review: Synovial cell metabolism and chronic inflammation in rheumatoid arthritis. Arthritis Rheumatol. 2018;70(7):984–999.
   PubMed Web of Science ®Google Scholar
• Li C, Liu PP, Tang DD, et al. Targeting the RhoA-ROCK pathway to regulate T-cell homeostasis in hypoxia-induced pulmonary arterial hypertension. Pulm Pharmacol Ther. 2018;50:111–122.
   PubMedGoogle Scholar
• Ricker E, Chowdhury L, Yi W, et al. The RhoA-ROCK pathway in the regulation of T and B cell responses. F1000Res. 2016;5:2295.
   Google Scholar
• Müller-Ladner U, Kriegsmann J, Franklin BN, et al. Synovial fibroblasts of patients with rheumatoid arthritis attach to and invade normal human cartilage when engrafted into SCID mice. Am J Pathol. 1996;149(5):1607–1615.
   PubMed Web of Science ®Google Scholar
• Pap T, Aupperle KR, Gay S, et al. Invasiveness of synovial fibroblasts is regulated by p53 in the SCID mouse in vivo model of cartilage invasion. Arthritis Rheum. 2001;44(3):676–681.
   PubMedGoogle Scholar
• Wei Q, Zhao Y, Yang ZQ, et al. Dishevelled family proteins are expressed in non-small cell lung cancer and function differentially on tumor progression. Lung Cancer. 2008;62(2):181–192.
   PubMedGoogle Scholar
• Khan AS, Hojjat-Farsangi M, Daneshmanesh AH, et al. Dishevelled proteins are significantly upregulated in chronic lymphocytic leukaemia. Tumour Biol. 2016;37(9):11947–11957.
   PubMedGoogle Scholar
• Sen M, Lauterbach K, El-Gabalawy H, et al. Expression and function of wingless and frizzled homologs in rheumatoid arthritis. Proc Natl Acad Sci USA. 2000;97(6):2791–2796.
   PubMed Web of Science ®Google Scholar
• Zhang L, Wrana JL. The emerging role of exosomes in wnt secretion and transport. Curr Opin Genet Dev. 2014;27:14–19.
   PubMed Web of Science ®Google Scholar
• Lopez-Verrilli MA, Court FA. Exosomes: mediators of communication in eukaryotes. Biol Res. 2013;46(1):5–11.
   PubMedGoogle Scholar
• Tan L, Wu H, Liu Y, et al. Recent advances of exosomes in immune modulation and autoimmune diseases. Autoimmunity. 2016;49(6):357–365.
   PubMed Web of Science ®Google Scholar
• Chen Z, Wang H, Xia Y, et al. Therapeutic potential of mesenchymal cell-derived miRNA-150-5p-Expressing exosomes in rheumatoid arthritis mediated by the modulation of MMP14 and VEGF. J Immunol. 2018;201(8):2472–2482.
   PubMed Web of Science ®Google Scholar
• Zhou W, He X, Chen Z, et al. LncRNA HOTAIR-mediated wnt/β-catenin network modeling to predict and validate therapeutic targets for cartilage damage. BMC Bioinformatics. 2019;20(1):412.
   PubMedGoogle Scholar
• Riazifar M, Mohammadi MR, Pone EJ, et al. Stem cell-derived exosomes as nanotherapeutics for autoimmune and neurodegenerative disorders. ACS Nano. 2019;13(6):6670–6688.
   PubMed Web of Science ®Google Scholar
• Zhang B, Yeo RWY, Lai RC, et al. Mesenchymal stromal cell exosome-enhanced regulatory T-cell production through an antigen-presenting cell-mediated pathway. Cytotherapy. 2018;20(5):687–696.
   PubMed Web of Science ®Google Scholar
• Nusse R, Clevers H. Wnt/β-Catenin signaling, disease, and emerging therapeutic modalities. Cell. 2017;169(6):985–999.
   PubMed Web of Science ®Google Scholar
• Raghu D, Xue HH, Mielke LA. Control of lymphocyte fate, infection, and tumor immunity by TCF-1. Trends Immunol. 2019;40(12):1149–1162.
   PubMedGoogle Scholar
• Qiu H, Wu H, Chan V, et al. Transcriptional and epigenetic regulation of follicular T-helper cells and their role in autoimmunity. Autoimmunity. 2017;50(2):71–81.
   PubMed Web of Science ®Google Scholar
• Chen Z, Ji Z, Ngiow SF, et al. TCF-1-centered transcriptional network drives an effector versus exhausted CD8 T cell-fate decision. Immunity. 2019;51(5):840–855.e5.
   PubMedGoogle Scholar
• Hudson WH, Gensheimer J, Hashimoto M, et al. Proliferating transitory T cells with an effector-like transcriptional signature emerge from PD-1+ stem-like CD8+ T cells during chronic infection. Immunity. 2019;51(6):1043–1058.e4.
   PubMedGoogle Scholar
• Johnson JL, Georgakilas G, Petrovic J, et al. Lineage-determining transcription factor TCF-1 initiates the epigenetic identity of T cells. Immunity. 2018;48(2):243–257.e10.
   PubMed Web of Science ®Google Scholar
• Zhu S, Liu H, Wu Y, et al. Wnt and rho GTPase signaling in osteoarthritis development and intervention: implications for diagnosis and therapy. Arthritis Res Ther. 2013;15(4):217.
   PubMed Web of Science ®Google Scholar
• Julian L, Olson MF. Rho-associated coiled-coil containing kinases (ROCK): structure, regulation, and functions. Small GTPases. 2014;5:e29846.
   PubMedGoogle Scholar
• Zanin-Zhorov A, Weiss JM, Nyuydzefe MS, et al. Selective oral ROCK2 inhibitor down-regulates IL-21 and IL-17 secretion in human T cells via STAT3-dependent mechanism. Proc Natl Acad Sci USA. 2014;111(47):16814–16819.
   PubMed Web of Science ®Google Scholar